Skip to main content

Animations

MJFF Publications

6721 - 6730 of 8826 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2019
  • 2019
  • 2017
  • 2017
  • 2017
  • 2017
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a neuroprotective phenotype in microglia
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1386-z
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-09633-9
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Parkinson's Disease Detection Using Isosurfaces-Based Features and Convolutional Neural Networks
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2019.00048
    Citation Count: 95
  • Summary Details
    OPEN
    Title: The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-019-1394-3
    Citation Count: 122
  • Summary Details
    OPEN
    Title: An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients
    Journal Name: Advances in Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12325-017-0571-2
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Neuropathological and transcriptomic characteristics of the aged brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.31126
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
    Journal Name: PLOS Medicine
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pmed.1002314
    Citation Count: 184
  • Summary Details
    OPEN
    Title: A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-017-01103-4
    Citation Count: 462
  • Summary Details
    OPEN
    Title: MAPT p.V363I mutation
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000347
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Genetic risk of Parkinson disease and progression:
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000348
    Citation Count: 161
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.